22 min listen
Acute Myeloid Leukemia with FLT3 Mutations
Acute Myeloid Leukemia with FLT3 Mutations
ratings:
Length:
38 minutes
Released:
Oct 30, 2020
Format:
Podcast episode
Description
For this special edition of Oncology Today, I met with Dr Keith Pratz from the University of Pennsylvania in Philadelphia to discuss recently published and emerging research in the use of FLT3 inhibitors for patients with acute myeloid leukemia.
CME information and select publications here (http://www.researchtopractice.com/OncologyTodayAMLFLT320).
CME information and select publications here (http://www.researchtopractice.com/OncologyTodayAMLFLT320).
Released:
Oct 30, 2020
Format:
Podcast episode
Titles in the series (100)
Dr Tom Lynch on Adjuvant EGFR TKIs in Lung Cancer and COVID-19 in Seattle: Dr Tom Lynch comments on the current status of oncology research and data soon to be presented from a Phase III trial evaluating the EGFR TKI osimertinib as adjuvant therapy for patients with non-small cell lung cancer and EGFR tumor mutations. by Oncology Today with Dr Neil Love